Enhancing the Treatment of Uncontrolled Inflammation through the Targeted Delivery of TPCA-1-Loaded Nanoparticles.

Chen, Zhaozhao; Tang, Lu; Luo, Lili; Luo, Wenjing; Li, Yingying; Wang, Xindi; Huang, Linlin; Hu, Yu; Mei, Heng

Chen, Zhaozhao; Tang, Lu; Luo, Lili; Luo, Wenjing; Li, Yingying; Wang, Xindi; Huang, Linlin; Hu, Yu; Mei, Heng.

Afiliación

Chen Z; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Tang L; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan 430022, China.
Luo L; Key Laboratory of Biological Targeted Therapy of Hubei Province, Wuhan 430022, China.
Luo W; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Li Y; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan 430022, China.
Wang X; Key Laboratory of Biological Targeted Therapy of Hubei Province, Wuhan 430022, China.
Huang L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Hu Y; Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan 430022, China.
Mei H; Key Laboratory of Biological Targeted Therapy of Hubei Province, Wuhan 430022, China.

Pharmaceutics ; 15(10)2023 Oct 09.

Article en En | MEDLINE | ID: mdl-37896195

Palabras clave

PECAM-1; TPCA-1; nanoparticles; targeted delivery; uncontrolled inflammation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google